KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

AbbVie (ABBV) Other Gross PP&E Adjustments (2016 - 2025)

AbbVie (ABBV) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with $13.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 16.82% to $13.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $13.5 billion, a 16.82% increase, with the full-year FY2025 number at $13.5 billion, up 16.82% from a year prior.
  • Other Gross PP&E Adjustments was $13.5 billion for Q4 2025 at AbbVie, up from $11.5 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $13.5 billion in Q4 2025 to a low of $10.7 billion in Q4 2021.
  • A 5-year average of $11.5 billion and a median of $11.0 billion in 2022 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: dropped 1.27% in 2021, then grew 16.82% in 2025.
  • AbbVie's Other Gross PP&E Adjustments stood at $10.7 billion in 2021, then increased by 2.5% to $11.0 billion in 2022, then decreased by 0.64% to $10.9 billion in 2023, then rose by 6.0% to $11.5 billion in 2024, then increased by 16.82% to $13.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Gross PP&E Adjustments are $13.5 billion (Q4 2025), $11.5 billion (Q4 2024), and $10.9 billion (Q4 2023).